EPCAM and posterior cortical atrophy: TCGA data revealed that EpCAM overexpression was not closely correlated with the clinicopathological characteristics in 495 patients with PCa, including age, pT stage, lymph node metastasis, number of lymph node, prostate-specific antigen (PSA) level, Gleason score, and biochemical recurrence.